Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-023-05291-6DOI Listing

Publication Analysis

Top Keywords

case donor
4
donor cell
4
cell leukemia
4
leukemia driven
4
driven novo
4
novo nras
4
nras mutation
4
mutation complex
4
complex karyotype
4
case
1

Similar Publications

Heart transplant candidates that are highly sensitized against human leukocyte antigens (HLA) face ongoing challenge in finding immunologically compatible donors. Desensitization strategies aimed at reducing HLA antibody titers have variable success rates. Imlifidase, a novel immunoglobulin G-degrading enzyme derived from Streptococcus pyogenes has been successfully used to eliminate pre-formed antibodies in sensitized kidney transplant recipients.

View Article and Find Full Text PDF

The use of donor eggs, sperm and embryos in medically assisted reproduction (MAR) provide new possibilities for reproductive assistance and family-making. In clinical practice, it also brings to light questions of responsibility and ethical conduct. Despite this, fertility practitioners' reasoning in clinical decision-making remains surprisingly understudied.

View Article and Find Full Text PDF

Background: Hair transplant surgery is often tended to as a last resort for different types of alopecia. It involves importing hair from a donor site to recipient site using different surgical tools. Surgical interventions hold the risk of causing complications, due to the penetration of skin and exposure of internal tissue to tools and outer environment.

View Article and Find Full Text PDF

A 63-year-old woman underwent living-donor kidney transplantation three years earlier for end-stage renal disease due to diabetic nephropathy, with her younger sister as the donor. She was prescribed calcium polystyrene sulfonate for the management of hyperkalemia, which had been discontinued two years earlier. At this time, she developed recurrent abdominal and urinary symptoms, which were managed empirically with antibiotics.

View Article and Find Full Text PDF

Introduction: Parkinson's disease (PD) is the second most common neurodegenerative disease with limited treatment options and increasing incidence. The Microbiota-Gut-Brain Axis (MGBA) offers new insights for PD treatment, as gut microbiota imbalances are linked to PD. Fecal microbiota transplantation (FMT) shows potential to improve gut dysbiosis and has gained attention for PD treatment.

View Article and Find Full Text PDF